Dr. Raj Gopalan, MD, MSIS, Vice President of Innovation & Clinical Informatics at Wolters Kluwer Clinical Drug Information (CDI) joins eHealth Radio and Health Care and Pharmaceutical Channels to discuss medication errors, the deadly problem no one is talking about.
Listen to interview with host Eric Michaels & guest Dr. Raj Gopalan discuss the following:
- he BMJ recently reported that medical errors have become the third leading cause of death in the U.S., and other reports note that the U.S. experiences some 124,000 deaths a year specifically due to medication errors. In your experience trying to improve medication safety, what are some examples of the types of medication errors you’ve encountered?
- What has changed over the years to make this more of a pressing issue?
- How can clinicians reduce these errors and what kind of solutions are currently available to help them?
- What are the next steps for the healthcare community? What developments need to be made to further and more effectively pursue the reduction of medication errors?
- You mentioned that Wolters Kluwer Clinical Drug Information is working on advancements to help address the issue of medication errors. What are some of those advancements, and how will they play a role in helping reduce medication errors?
Raj Gopalan, MD, MSIS, is the Vice President of Innovation & Clinical Informatics at Wolters Kluwer Clinical Drug Information (CDI), focused on developing next-generation of health information technology and clinical decision support innovations to help enable healthcare organizations to deliver precision care to patients with utmost efficiency.
Prior to joining Wolters Kluwer, Dr. Gopalan has served as a Clinical Architect and Medical Director of a large academic medical center, and as a CMIO of a large multihospital integrated delivery networks. He has also worked as a Clinical Architect for technology companies. In previous roles, he has designed, developed and implemented EMR systems across multiple community and urban hospitals.
Follow Wolters Kluwer Clinical Drug Information: